Solvias redefines Asian engagement with focus on analytical services
With Asia evolving as a research and development hub of the global pharmaceutical industry, Solvias is advancing analytical services to help companies in the region gain better access to the highly regulated Western markets.
With Asia evolving as a research and development hub of the global pharmaceutical industry, Solvias is advancing analytical services to help companies in the region gain better access to the highly regulated Western markets.
"The investment for developing a drug and getting it to the marketplace has significantly increased over the past years," says Dr Karen Huebscher, CEO. "It is imperative to understand the product as early as possible to avoid huge costs later on."
Increasing globalisation has raised the stakes especially in pharmaceuticals, where manufacturing and laboratory practices are held to universal standards. For instance, current testing requirements include heavy metals, extractables and leachables, which hardly caused any concern just a decade ago.
While Solvias is better known in Asia for its expertise in solid-state technology and synthesis capabilities for ligands, the company has an excellent reputation globally for its analytical services. Clients throughout the industry, including all large pharmaceutical companies, have relied on Solvias for its broad array of methodologies.
"What we bring to the discussion with government bodies is our expertise in the evaluation of analytical methods," Huebscher says. "We provide value-adding services tailored to the specific molecule.
For instance, we can assist in understanding its characteristics in depth and support the regulatory process to bring the product to the marketplace."
Comprehensive knowledge on small and large molecules and active pharmaceutical ingredients is critical in pharmaceuticals, biotechnology, medical technology and cosmetics.
At the forefront of innovation, Solvias is launching a sterility test methodology that cuts processing time from two weeks to five days. Its sample preparation laboratory in Switzerland is built entirely of plastic to rule out any cross-contamination during heavy metal testing. A proprietary database of extractables and leachables further ensures credible results.
"It's our mission to provide unrivalled expertise so that our customers can bring safe and better products to the market faster," Huebscher says.
http://www.solvias.com
